Studies on hydrolytic and oxidative metabolic pathways of anhydroecgonine methyl ester (methylecgonidine) using microsomal preparations from rat organs

Chemical Research in Toxicology

Volumn 15, Issue 12, 2002, Pages 1543-1548

  Fandiño, Anabel S ^a   Toennes, Stefan W ^a   Kauert, Gerold F ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; COCAINE; ECGONINE METHYL ESTER; METHYLECGONIDINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN MICROSOME; CYTOTOXICITY; DRUG METABOLISM; GAS CHROMATOGRAPHY; HYDROLYSIS; KIDNEY MICROSOME; LIVER MICROSOME; LUNG; MASS SPECTROMETRY; MICROSOME; NONHUMAN; OXIDATION; PYROLYSIS; RAT;

ANIMALS; BRAIN; CATALYSIS; COCAINE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROLYSIS; ISOCITRATE DEHYDROGENASE; KIDNEY; LUNG; MALE; MICROSOMES; MICROSOMES, LIVER; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0036914195     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0255828     Document Type: Article

References (24)

1. Nakahara, Y., and Ishigami, A. (1991) Inhalation efficiency of free-base cocaine by pyrolysis of 'crack' and cocaine hydrochloride. J. Anal. Toxicol. 15, 105-109.
2. Paul, B. D., McWhorter, L. K., and Smith, M. L. (1999) Electron ionization mass fragmentometric detection of urinary ecgonidine, a hydrolytic product of methylecgonidine, as an indicator of smoking cocaine. J. Mass. Spectrom. 34, 651-660.
3. Scheidweiler, K. B., Shojaie, J., Plessinger, M. A., Wood, R. W., and Kwong, T. C. (2000) Stability of methylecgonidine and ecgonidine in sheep plasma in vitro. Clin. Chem. 46, 1787-1795.
4. Fandino, A. S., Toennes, S. W., and Kauert, G. F. (2002) Studies on in-vitro degradation of anhydroecgonine methyl ester (methylecgonidine) in human plasma. J. Anal. Toxicol. (in press).
5. Fandino, A. S., Karas, M., Toennes, S. W., and Kauert, G. (2002) Identification of anhydroecgonine methyl ester N-oxide, a new metabolite of anhydroecgonine methyl ester, using electrospray mass spectrometry. J. Mass. Spectrom. 37, 525-532.
6. Zhang, J. Y., and Foltz, R. L. (1990) Cocaine metabolism in man: Identification of four previously unreported cocaine metabolites in human urine. J. Anal. Toxicol. 14, 201-205.
7. Brzezinski, M. R., Spink, B. J., Dean, R. A., Berkman, C. E., Cashman, J. R., and Bosron, W. F. (1997) Human liver carboxylesterase hCE-1: Binding specificity for cocaine, heroin, and their metabolites and analogs. Drug Metab. Dispos. 25, 1089-1096.
8. Dean, R. A., Zhang, J., Brzezinski, M. R., and Bosron, W. F. (1995) Tissue distribution of cocaine methyl esterase and ethyl transferase activities: Correlation with carboxylesterase protein. J. Pharmacol. Exp. Ther. 275, 965-971.
9. Boelsterli, U. A., and Göldlin, C. (1991) Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch. Toxicol. 65, 351-360.
10. Thompson, M. L., Shuster, L., and Shawk, K. (1979) Cocaine-induced hepatic necrosis in mice, the role of cocaine metabolism. Biochem. Pharmacol. 28, 2389-2395.
11. Misra, A. L., Pontani, R. B., and Vadlamani, N. L. (1979) Metabolism of norcocaine, N-hydroxy norcocaine and cocaine-N- oxide in the rat. Xenobiotica 9, 189-199.
12. Shuster, L., Casey, E., and Welankiwar, S. S. (1983) Metabolism of cocaine and norcocaine to N-hydroxynorcocaine. Biochem. Pharmacol. 32, 3045-3051.
13. Rauckman, E. J., Rosen, G. M., and Cavagnaro, J. (1982) Norcocaine nitroxide, a potential hepatotoxic metabolite of cocaine. Mol. Pharmacol. 21, 458-463.
14. Kloss, M. W., Cavagnaro, J., Rosen, G. M., and Rauckman, E. J. (1982) Involvement of FAD-containing monooxygenase in cocaine-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 64, 88-93.
15. Kloss, M. W., Rosen, G. M., and Rauckman, E. J. (1984) Biotrans-formation of norcocaine to norcocaine nitroxide by rat brain microsomes. Psychopharmacology 84, 221-224.
16. Pellinen, P., Honkakoski, P., Stenbäck, F., Niemitz, M., Alhava, E., Pelkonen, O., Lang, M., and Pasanen, M. (1994) Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur. J. Pharmacol. 270, 35-43.
17. Kraemer, T., Bickeboeller-Friedrich, J., and Maurer, H. H. (2000) On the metabolism of the amphetamine-derived antispasmodic drug mebeverine: Gas chromatography-mass spectrometry studies on rat liver microsomes and on human urine. Drug Metab. Dispos. 28, 339-347.
18. Boyer, C. S., and Petersen, D. R. (1992) Enzymatic basis for the transesterification of cocaine in the presence of ethanol: Evidence for the participation of microsomal carboxylesterases. J. Pharmacol. Exp. Ther. 260, 939-946.
19. Cymerman, C. J., and Purushothaman, K. K. (1970) An improved preparation of tertiary amine N-oxides. J. Org. Chem. 35, 1721-1722.
20. Kozikowski, A. P., Saiah, M. K. E., Johnson, K. M., and Bergmann, J. S. (1995) Chemistry and biology of the 2β-alkyl-3βphenyl analogues of cocaine: Subnanomolar affinity ligands that suggest a new pharmacophore model at the C-2 position. J. Med. Chem. 38, 3086-3093.
21. Ndikum-Moffor, F. M., Schoeb, T. R., and Roberts, S. M. (1998) Liver toxicity from norcocaine nitroxide, and N-oxidative metabolite of cocaine. J. Pharmacol. Exp. Ther. 284, 413-419.
22. Jindal, S. P., and Lutz, T. (1989) Mass spectrometric studies of cocaine disposition in animals and humans using stable isotope-labeled analogues. J. Pharm. Sci. 78, 1009-1014.
23. Satoh, T. a. H. M. (1998) The mammalian carboxylesterases: From molecules to function. Annu. Rev. Pharmacol. Toxicol. 38, 257-288.
24. Cummings, B. S., Zangar, R. C., Novak, R. F., and Lash, L. H. (1999) Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metab. Dispos. 27, 542-548.